Jeff Yass’s Aravive, Inc. Common Stock ARAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-58,800
Closed -$74.1K 13298
2023
Q2
$74.1K Sell
58,800
-44,200
-43% -$71.7K ﹤0.01% 11147
2023
Q1
$206K Sell
103,000
-41,200
-29% -$77.4K ﹤0.01% 10533
2022
Q4
$190K Buy
+144,200
New +$184K ﹤0.01% 10202
2021
Q4
Sell
-27,800
Closed -$103K 14149
2021
Q3
$103K Buy
+27,800
New +$119K ﹤0.01% 12056
2020
Q3
Sell
-22,000
Closed -$256K 11317
2020
Q2
$256K Buy
+22,000
New +$261K ﹤0.01% 8634
2020
Q1
Sell
-88,500
Closed -$1.21M 11071
2019
Q4
$1.21M Buy
88,500
+66,100
+295% +$584K ﹤0.01% 5152
2019
Q3
$168K Buy
22,400
+1,100
+5% +$6.86K ﹤0.01% 9242
2019
Q2
$128K Buy
21,300
+200
+0.9% +$1.25K ﹤0.01% 9483
2019
Q1
$149K Sell
21,100
-9,200
-30% -$48K ﹤0.01% 8057
2018
Q4
$107K Buy
30,300
+18,900
+166% +$109K ﹤0.01% 8188
2018
Q3
$96K Sell
11,400
-6,567
-37% -$69.2K ﹤0.01% 8621
2018
Q2
$218K Buy
17,967
+2,417
+16% +$24.9K ﹤0.01% 8465
2018
Q1
$154K Buy
15,550
+12,217
+367% +$137K ﹤0.01% 8510
2017
Q4
$44K Sell
3,333
-4,184
-56% -$53.9K ﹤0.01% 8941
2017
Q3
$110K Sell
7,517
-10,116
-57% -$1.02M ﹤0.01% 8325
2017
Q2
$1.85M Buy
17,633
+5,750
+48% +$618K ﹤0.01% 4051
2017
Q1
$1.52M Buy
+11,883
New +$1.25M ﹤0.01% 4242

Other funds holding ARAV

Jeff Yass's ARAV Position: Q1 2024 in Review

Jeff Yass sold out of Aravive, Inc. Common Stock (ARAV) in Q1 2024, closing a stake of 25,413 shares — an estimated $3.14K sold.

Jeff Yass first reported a position in ARAV in Q4 2016 and held it in 15 quarters. The position peaked at $750K in Q4 2016. 3 funds tracked by Wall St. Rank hold ARAV as of Q1 2024.

  • Jeff Yass reported no remaining Aravive, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Jeff Yass sold 25,413 Aravive, Inc. Common Stock shares in Q1 2024, an estimated $3.14K.
  • Jeff Yass first reported a position in Aravive, Inc. Common Stock in Q4 2016 and held it in 15 quarters.
  • Jeff Yass's Aravive, Inc. Common Stock position peaked at $750K in Q4 2016.
  • 3 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q1 2024.

Based on Susquehanna International Group's 13F filing for Q1 2024, filed 7 May 2024.